FRCPath Haem Part 1 MCQ-Oncology 326
- amirhayat2527
- Dec 27, 2025
- 0 min read
A 55yr-old pt with B-ALL relapses after first-line therapy. He has 40% marrow blasts. Which agent is most appropriate to achieve deep cytoreduction?
Blinatumomab
Inotuzumab
Nelarabine
CAR-T therapy

